Finch Therapeutics Group, Inc. (FNCH)
NASDAQ: FNCH · IEX Real-Time Price · USD
1.940
-0.010 (-0.51%)
At close: May 17, 2024, 4:00 PM
1.870
-0.070 (-3.61%)
After-hours: May 17, 2024, 4:08 PM EDT

Finch Therapeutics Group Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for FNCH.

Analyst Consensus: n/a
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

There are currently no analyst ratings available for FNCH.

Recommendation Trends

Rating Dec '22Jan '23Feb '23Mar '23Apr '23May '23
Strong Buy 222220
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 222220

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$210
Strong Buy Reiterates $210 +10,724.74% May 12, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$510$210
Strong Buy Reiterates $510$210 +10,724.74% Apr 4, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$510
Strong Buy Initiates $510 +26,188.66% Aug 9, 2022
Jefferies
Jefferies
Strong Buy
Maintains
$870$510
Strong Buy Maintains $870$510 +26,188.66% Apr 4, 2022
Evercore ISI Group
Evercore ISI Group
Buy
Initiates
n/a
Buy Initiates n/a n/a Apr 13, 2021
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 107.00K
Revenue Next Year
90.27M
EPS This Year
-21.00
from -46.59
EPS Next Year
n/a
from -21.00
Year 2019202020212022202320242025
Revenue
10.15M7.72M18.53M861.00K107.00K-90.27M
Revenue Growth
--23.98%140.08%-95.35%-87.57%--
EPS
-85.20-144.90-44.40-72.12-46.59-21.00-
EPS Growth
-------
No. Analysts -----43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025
High n/a 92.9M
Avg n/a 90.3M
Low n/a 86.7M

Revenue Growth

Revenue Growth 20242025
High - -
Avg - -
Low - -

EPS Forecast

EPS 2024
High -21.62
Avg -21.00
Low -20.18

EPS Growth

EPS Growth 2024
High -
Avg -
Low -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.